Related Experiment Video
Updated: Feb 5, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Diagnosis, management and pathophysiology of central sleep apnea in children
Anya T McLaren1, Saadoun Bin-Hasan2, Indra Narang3
1Division of Respiratory Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G1X8, Canada.
Insights
Central sleep apnea (CSA) affects 1-5% of healthy children, and is more common in those with underlying conditions. Early diagnosis and tailored management, including ventilation or surgery, improve outcomes for pediatric CSA.
Area of Science:
- Pediatric Pulmonology
- Sleep Medicine
- Pediatric Neurology
Background:
- Central sleep apnea (CSA) affects 1-5% of healthy children.
- CSA prevalence increases significantly in children with underlying medical conditions.
- The presence of CSA can impact disease progression in pediatric patients.
Purpose of the Study:
- To review the pathophysiology, prevalence, and diagnosis of central sleep apnea in children.
- To outline a management algorithm for pediatric CSA, considering healthy children and those with comorbidities.
- To emphasize the importance of early screening and diagnosis for high-risk pediatric populations.
Main Methods:
- Literature review on pediatric central sleep apnea.
- Classification of CSA based on hypercapnia and associated conditions.
- Development of a management algorithm for pediatric CSA.
Main Results:
- CSA is classified by hypercapnia and underlying etiology.
- Management strategies for pediatric CSA are patient-specific.
- Treatment options include medication, non-invasive ventilation, and surgical intervention.
Conclusions:
- Early identification of pediatric CSA is crucial for timely intervention.
- Tailored management plans are essential for improving outcomes in children with CSA.
- Screening high-risk children can lead to earlier diagnosis and treatment.
Abstract:
Central sleep apnea (CSA) is thought to occur in about 1-5% of healthy children. CSA occurs more commonly in children with underlying disease and the presence of CSA may influence the course of their disease. CSA can be classified based on the presence or absence of hypercapnia as well as the underlying condition it is associated with. The management of CSA needs to be tailored to the patient and may include medication, non-invasive ventilation, and surgical intervention. Screening children at high risk will allow for earlier diagnosis and timely therapeutic interventions for this population. The review will highlight the pathophysiology, prevalence and diagnosis of CSA in children. An algorithm for the management of CSA in healthy children and children with underlying co-morbidities will be outlined.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
The Central Dogma
Pneumonia II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension II: Pathophysiology

